The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus

Introduction/objectivesIn 2012, hypocomplementemia was included in the classification criteria of systemic lupus erythematosus (SLE). The suggested measurement of C3 or C4 often reflect disease activity poorly. Our objective was to establish an assay measuring C3dg, which is generated following comp...

Full description

Bibliographic Details
Main Authors: Anne Troldborg, Lisbeth Jensen, Bent Deleuran, Kristian Stengaard-Pedersen, Steffen Thiel, Jens Christian Jensenius
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2018.00581/full
_version_ 1819095746005172224
author Anne Troldborg
Anne Troldborg
Lisbeth Jensen
Bent Deleuran
Bent Deleuran
Kristian Stengaard-Pedersen
Kristian Stengaard-Pedersen
Steffen Thiel
Jens Christian Jensenius
author_facet Anne Troldborg
Anne Troldborg
Lisbeth Jensen
Bent Deleuran
Bent Deleuran
Kristian Stengaard-Pedersen
Kristian Stengaard-Pedersen
Steffen Thiel
Jens Christian Jensenius
author_sort Anne Troldborg
collection DOAJ
description Introduction/objectivesIn 2012, hypocomplementemia was included in the classification criteria of systemic lupus erythematosus (SLE). The suggested measurement of C3 or C4 often reflect disease activity poorly. Our objective was to establish an assay measuring C3dg, which is generated following complement activation, and to evaluate the assay in a cross-sectional SLE cohort.MethodWe included SLE patients (n = 169) and controls (n = 170) and developed a modified C3dg assay where C3dg fragments were separated from the large plasma proteins by polyethylene glycol (PEG), and the supernatant containing the C3dg fragment was used for analysis in an antibody-based sandwich-type assay. Gel permeation chromatography and western blotting were used to establish the optimal conditions for PEG precipitation.Results16% PEG was optimal for separating C3dg from C3 and the larger protein fragments. The assay showed a high degree of stability when using EDTA plasma, and measurements correlated well with commercially available complement activation assays. SLE patients had higher concentrations in plasma of C3dg than controls (p < 0.05). ROC analysis showed that the C3dg activation fragment of C3 with an AUC of 0.96 (CI 0.94–0.98) was superior to C3 (AUC 0.52) in differentiating between patients and controls.ConclusionOur results present a modified assay for the measurement of C3dg. We demonstrate that C3dg was superior to conventional C3 measurements in discriminating SLE patients from controls. We suggest that C3dg should be considered as a complement activation measurement in the SLE classification criteria.
first_indexed 2024-12-21T23:48:12Z
format Article
id doaj.art-d26dc7b3e02645069cadfeb59a00d253
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-21T23:48:12Z
publishDate 2018-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-d26dc7b3e02645069cadfeb59a00d2532022-12-21T18:46:00ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-03-01910.3389/fimmu.2018.00581339994The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus ErythematosusAnne Troldborg0Anne Troldborg1Lisbeth Jensen2Bent Deleuran3Bent Deleuran4Kristian Stengaard-Pedersen5Kristian Stengaard-Pedersen6Steffen Thiel7Jens Christian Jensenius8Department of Rheumatology, Aarhus University Hospital, Aarhus, DenmarkInstitute of Clinical Medicine, Aarhus University, Aarhus, DenmarkDepartment of Biomedicine, Aarhus University, Aarhus, DenmarkDepartment of Rheumatology, Aarhus University Hospital, Aarhus, DenmarkDepartment of Biomedicine, Aarhus University, Aarhus, DenmarkDepartment of Rheumatology, Aarhus University Hospital, Aarhus, DenmarkInstitute of Clinical Medicine, Aarhus University, Aarhus, DenmarkDepartment of Biomedicine, Aarhus University, Aarhus, DenmarkDepartment of Biomedicine, Aarhus University, Aarhus, DenmarkIntroduction/objectivesIn 2012, hypocomplementemia was included in the classification criteria of systemic lupus erythematosus (SLE). The suggested measurement of C3 or C4 often reflect disease activity poorly. Our objective was to establish an assay measuring C3dg, which is generated following complement activation, and to evaluate the assay in a cross-sectional SLE cohort.MethodWe included SLE patients (n = 169) and controls (n = 170) and developed a modified C3dg assay where C3dg fragments were separated from the large plasma proteins by polyethylene glycol (PEG), and the supernatant containing the C3dg fragment was used for analysis in an antibody-based sandwich-type assay. Gel permeation chromatography and western blotting were used to establish the optimal conditions for PEG precipitation.Results16% PEG was optimal for separating C3dg from C3 and the larger protein fragments. The assay showed a high degree of stability when using EDTA plasma, and measurements correlated well with commercially available complement activation assays. SLE patients had higher concentrations in plasma of C3dg than controls (p < 0.05). ROC analysis showed that the C3dg activation fragment of C3 with an AUC of 0.96 (CI 0.94–0.98) was superior to C3 (AUC 0.52) in differentiating between patients and controls.ConclusionOur results present a modified assay for the measurement of C3dg. We demonstrate that C3dg was superior to conventional C3 measurements in discriminating SLE patients from controls. We suggest that C3dg should be considered as a complement activation measurement in the SLE classification criteria.http://journal.frontiersin.org/article/10.3389/fimmu.2018.00581/fullcomplement systemcomplement activationsystemic lupus erythematosusbiomarkerdiagnostics
spellingShingle Anne Troldborg
Anne Troldborg
Lisbeth Jensen
Bent Deleuran
Bent Deleuran
Kristian Stengaard-Pedersen
Kristian Stengaard-Pedersen
Steffen Thiel
Jens Christian Jensenius
The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus
Frontiers in Immunology
complement system
complement activation
systemic lupus erythematosus
biomarker
diagnostics
title The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus
title_full The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus
title_fullStr The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus
title_full_unstemmed The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus
title_short The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus
title_sort c3dg fragment of complement is superior to conventional c3 as a diagnostic biomarker in systemic lupus erythematosus
topic complement system
complement activation
systemic lupus erythematosus
biomarker
diagnostics
url http://journal.frontiersin.org/article/10.3389/fimmu.2018.00581/full
work_keys_str_mv AT annetroldborg thec3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT annetroldborg thec3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT lisbethjensen thec3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT bentdeleuran thec3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT bentdeleuran thec3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT kristianstengaardpedersen thec3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT kristianstengaardpedersen thec3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT steffenthiel thec3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT jenschristianjensenius thec3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT annetroldborg c3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT annetroldborg c3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT lisbethjensen c3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT bentdeleuran c3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT bentdeleuran c3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT kristianstengaardpedersen c3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT kristianstengaardpedersen c3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT steffenthiel c3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus
AT jenschristianjensenius c3dgfragmentofcomplementissuperiortoconventionalc3asadiagnosticbiomarkerinsystemiclupuserythematosus